Studies confirm that hormone levels in trans women are not greatly affected by PrEP, or vice versa
Modelling suggests injectable cabotegravir is far more effective than daily oral PrEP for women
How can HIV research better align with the realities of transgender and gender-diverse people?
Shorter, less toxic treatment for highly drug-resistant TB cures nine out of ten
Earlier treatment and higher CD4 counts linked to smaller HIV reservoir
PrEP failures in African programmes are rare, but some are happening in people with good adherence
Viral suppression in Uganda improved by more viral load tests, done faster
Multiple African countries improved access to HIV treatment during COVID-19 pandemic
Long-acting injectable HIV treatment is feasible, even during COVID-19
